Chemoinformaics analysis of 8-Deoxyserratinine
| Molecular Weight | 263.381 | nRot | 0 |
| Heavy Atom Molecular Weight | 238.181 | nRig | 20 |
| Exact Molecular Weight | 263.189 | nRing | 4 |
| Solubility: LogS | -1.786 | nHRing | 2 |
| Solubility: LogP | 2.255 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 25 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 46.0938 |
| nHD | 1 | BPOL | 27.6582 |
| QED | 0.726 |
| Synth | 5.289 |
| Natural Product Likeliness | 2.494 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.988 |
| HIA | 0.041 |
| CACO-2 | -4.878 |
| MDCK | 0.00000614 |
| BBB | 0.969 |
| PPB | 0.118003 |
| VDSS | 2.725 |
| FU | 0.842283 |
| CYP1A2-inh | 0.032 |
| CYP1A2-sub | 0.586 |
| CYP2c19-inh | 0.075 |
| CYP2c19-sub | 0.947 |
| CYP2c9-inh | 0.118 |
| CYP2c9-sub | 0.179 |
| CYP2d6-inh | 0.23 |
| CYP2d6-sub | 0.455 |
| CYP3a4-inh | 0.416 |
| CYP3a4-sub | 0.91 |
| CL | 13.759 |
| T12 | 0.622 |
| hERG | 0.034 |
| Ames | 0.109 |
| ROA | 0.879 |
| SkinSen | 0.067 |
| Carcinogencity | 0.857 |
| EI | 0.029 |
| Respiratory | 0.961 |
| NR-Aromatase | 0.023 |
| Antiviral | Yes |
| Prediction | 0.605001 |